HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viswanath Das Selected Research

Viswanath Das Research Topics

Disease

12Neoplasms (Cancer)
11/2023 - 12/2012
7Alzheimer Disease (Alzheimer's Disease)
03/2024 - 09/2014
6Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 12/2012
4Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 07/2017
3Tauopathies
01/2023 - 12/2012
3Hypoxia (Hypoxemia)
01/2018 - 04/2015
2Inflammation (Inflammations)
11/2023 - 10/2023
2Parkinson Disease (Parkinson's Disease)
10/2023 - 01/2020
1Dementia (Dementias)
03/2024
1Multiple Sclerosis
01/2023
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023
1Virus Diseases (Viral Diseases)
01/2023
1Disease Progression
01/2023
1Neoplasm Metastasis (Metastasis)
01/2021
1Pick Disease of the Brain (Pick's Disease)
01/2020
1Frontotemporal Dementia With Motor Neuron Disease
01/2020
1Carcinogenesis
08/2014
1Neuroblastoma
12/2012

Drug/Important Bio-Agent (IBA)

5EnzymesIBA
01/2021 - 08/2014
3Protein Isoforms (Isoforms)IBA
01/2023 - 12/2012
3tau Proteins (tau Protein)IBA
02/2022 - 09/2014
2Phosphotransferases (Kinase)IBA
02/2022 - 11/2017
2PrionsIBA
01/2022 - 01/2021
2Carbonic Anhydrase IXIBA
08/2020 - 11/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2018
2peloruside AIBA
01/2018 - 07/2017
2Paclitaxel (Taxol)FDA LinkGeneric
07/2017 - 12/2012
2Taxoids (Taxanes)IBA
04/2015 - 12/2012
1Antineoplastic Agents (Antineoplastics)IBA
03/2024
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2023
1diazonaphthalenedisulfonic acid (NDS)IBA
10/2023
1Drug CombinationsIBA
01/2023
1NucleosidesIBA
01/2023
1pyrimidineIBA
01/2023
1purineIBA
01/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2019
1DecitabineFDA Link
01/2018
1Azacitidine (5 Azacytidine)FDA Link
01/2018
1Conditioned Culture MediaIBA
01/2018
1TubulinIBA
07/2017
1Vincristine (Oncovin)FDA LinkGeneric
07/2017
1Proteins (Proteins, Gene)FDA Link
04/2015
1Neuroprotective AgentsIBA
09/2014
1tyrosyltubulin ligaseIBA
08/2014

Therapy/Procedure

10Therapeutics
03/2024 - 12/2012
1Immunotherapy
01/2018